Viewing StudyNCT00488397



Ignite Creation Date: 2024-05-05 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00488397
Status: COMPLETED
Last Update Posted: 2011-03-22
First Post: 2007-06-18

Brief Title: Tigecycline In-Vitro Surveillance Study In Taiwan
Sponsor:
Organization: Wyeth is now a wholly owned subsidiary of Pfizer

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 7902
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
3381
Who Masked List: